Jyh-Pyng Gau

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

Yi‐Hsiang Huang, Liang-Tsai Hsiao, Ying-Chung Hong et al. · Journal of Clinical Oncology · 2013 · 327 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.

William Zhang, Craig J. McClain, Jyh-Pyng Gau et al. · PubMed · 1994 · 48 citations

Life Sciences, Cancer Biology, Molecular Biology +12

Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia

Chih‐Cheng Chen, Ching‐Fen Yang, Mu Yang et al. · Annals of Oncology · 2005 · 47 citations · Full text

Medicine, Hematology, Oncology +17

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

Yu-Chung Huang, Chia‐Jen Liu, Chun‐Yu Liu et al. · Annals of Hematology · 2011 · 42 citations

Medicine, Immunology, Internal Medicine +12